Selected References by StemCyte Principal Investigators & on Plasma Depleted Cord Blood Stem Cell Products

Size: px
Start display at page:

Download "Selected References by StemCyte Principal Investigators & on Plasma Depleted Cord Blood Stem Cell Products"

Transcription

1 Selected References by StemCyte Principal Investigators & on Plasma Depleted Cord Blood Stem Cell Products Petz L. ed. Wagner J, Champlin R, & Petz L, Proceedings of the 2 nd Annual International Cord Blood Transplantation Symposium Biol. Blood & Marrow Transplantation (2004) 10: Wagner J, Champlin R, & Petz L, Proceedings of the 3 rd Annual International Cord Blood Transplantation Symposium Biol. Blood & Marrow Transplantation (2005) 11: Wagner J, Champlin R, & Petz, L, Proceedings of the 4 th Annual International Cord Blood Transplantation Symposium Biol. Blood & Marrow Transplantation (2006) In Press Clinical Bone Marrow Transplantation. K.G. Blume and L.D. Petz, Editors. Churchill Livingstone, New York, pages. Clinical Practice of Transfusion Medicine (2 nd ed). L.D. Petz and S.N. Swisher, editors. Churchill Livingstone, New York, pages. Clinical Practice of Transfusion Medicine(3 rd ed). LD Petz, SN Swisher, S. Kleinman, R. Spence and R. Strauss, eds. Churchill-Livingstone, New York, 1995, 1115 pages. Acquired Immune Hemolytic Anemias. LD Petz and G Garratty, 2nd Edition. IN PRESS Forman S, Petz LD. Major Radiation Exposure. New Eng J Med 2002; 347:944-7 Branch, D.R., Gallagher, M.T., Forman, S.J., Winkler, K.J., Petz L.D., and Blume, K.G.: Endogenous stem cell repopulation resulting in mixed hematopoietic chimerism following total body irradiation and marrow transplantation for acute leukemia. Transplantation 34: , Ritchey, B., Henry, S., Forman, S.J., Spruce, W.E., Petz L.D., and Blume, K.G.: Bone marrow transplantation for patients with major ABO incompatibility. Transplantation 35:638, Petz LD: The development of bone marrow transplantation. IN: Clinical Bone Marrow Transplantation (K.G. Blume and L.D. Petz, eds). Churchill Livingstone, New York, pp Petz L.D. and Scott, E.P.: Supportive therapy. IN Clinical Bone Marrow Transplantation (K.G. Blume and L.D. Petz, eds). Churchill Livingstone, pp Hows, J., Beddow, K., Gordon-Smith, E., Branch, D., Spruce, W., Sniecinski, I. and Petz L.D.,: Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood, 67: , Petz L.D.,: Immunohematologic problems unique to bone marrow transplantation. IN Red Cell Antigens and Antibodies (G. Garratty, ed) American Association of Blood Banks, Arlington, VA, 1986, pp Petz L.D., Yam, P.Y., Wallace, R.B., Stock, A.D., de Lange, G., Knowlton, R.G., Brown, V.A., Donis-Keller, H., Blume, K.G.: Mixed Hematopoietic chimerism following bone marrow transplantation for hematopoietic malignancies: Incidence, characterization, and implications for GVHD and leukemic relapse. IN Recent Advances in Bone Marrow Transplantation (R.P. Gale, R. Champlin, eds.) UCLA Symposia on Molecular and Cellular Biology. Alan R. Liss, Inc., New York, NY. New Series, Vol 53 (1986). Yam, P.Y., Petz L.D., Knowlton, R.G., Wallace, R.B., Stock, A.D., de Lange, G., Brown, V.A., Donis-Keller, H., Blume, K.G.: Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation, 43: , Transplantation Outcome & Selected References on StemCyte & Plasma Depleted Cord Blood Stem Cell Products Page 2

2 Yam, P.Y., Petz L.D., Ali, S., Stock, A.D., Wallace, R.B.: Development of a single probe for documentation of chimerism following bone marrow transplantation. American Journal of Human Genetics, 41: , Petz L.D.,: Immunohematologic problems associated with bone marrow transplantation. Transfusion Medicine Reviews, 1:85-100, Petz L.D., Yam, P.Y., Wallace, R.B., Stock, A.D., de Lange, G., Knowlton, R.G., Brown, V.A., Donis-Keller, H., Hill, L.R., Forman, S.J. and Blume, K.G.: Mixed Hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood, 70: , Champlin RE, Ho WG, Nimer SD, Gajewski JG, Selch M, Burnison M, Holley G, Yam P, Petz LD, Winston DJ, and Feig SA: Bone marrow transplantation for severe aplastic anemia. Transplantation 49: , Champlin R, Ho W, Gajewski J, Feig S, Burnison M, Holley G, Greenberg P, Lee K, Schmid I, Giorgi J, Yam P, Petz L, Winston D, Warner N, Reichert T: Selective depletion of CD8+ lymphocytes-t for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood 76: , Ugozzoli L, Yam P, Petz LD, Ferrara GB, Champlin RE, Forman SJ, Koyal D, Wallace RB: Amplification by the polymerase chain reaction of hypervariable regions of the human genome for the evaluation of chimerism following bone marrow transplantation. Blood 77: , Petz LD: The expanding boundaries of transfusion medicine. IN: Clinical and Basic Science Aspects of Immunohematology (Nance SJ, ed). American Association of Blood Banks (Emily Cooley Award Lecture), Arlington VA, pp , Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NO, Hunt LA, Schiller GJ, Ho WG, Champlin RE: Hemolysis of transfused group O RBC in minor ABO-incompatible unrelated donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 79: , Petz LD: Documentation of engraftment and characterization of chimerism following bone marrow transplantation. IN: Bone Marrow Transplantation (Forman SJ, Blume KG, Thomas ED, eds.) Blackwell Scientific Publications, Inc. pp , Petz LD: Bone Marrow Transplantation. IN: Clinical Practice of Transfusion Medicine (3rd ed). (Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RG, eds.) Churchill-Livingstone, New York, 1996, pp Gajewski J, Gjertson D, Cecka M, Tonai R, Przepiorka D, Hunt L, Giralt S, Chan KW, Feig S, Territo M, Andersson B, van Besien K, Khouri I, Fischer H, Babbitt L, Ippolitti C, Schiller G, Lill M, Warkentin D, Neumann J, Petz LD, Terasaki P, Champlin R: The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation. Biol Blood Marrow Transplant 3:76-82, Petz LD: Hemolysis associated with transplantation. Transfusion 38: 224, 1998 (editorial). Jaing T, Hung I, Yang C, Lin T, Chow R, Hsieh S, Successful Unrelated Cord Blood Transplantation in a Child with Beta-Thalassemia Major J. Trop. Ped. (2005) 51: Jaing T, Hung I, Yang C, Chen S, Sun C, and Chow R, Rapid and Complete Donor Chimerism After Unrelated Mismatched Cord Blood Transplantation in Five Children with Beta-Thalassemia Major Biol. Blood & Marrow Transplantation (2005) 11: Poh SB, Hsiao LT, Yang CF, Chiou TJ, Chen PM, Fatal early-onset Epstein-Barr virus associated posttransplantation lymphoproliferative disease after successful adult dual-unit umbilical cord blood transplantation. Biol. Blood & Marrow Transplantation (2005) 11: Hung GY, Chiou TJ, Chang CY, Teng HW, Chen PM, & Hwang B, Double-Unit Unrelated Cord Blood Transplantation on Chronic Myelogenous Leukemia International Journal of Hematology (2005) 82: Transplantation Outcome & Selected References on StemCyte & Plasma Depleted Cord Blood Stem Cell Products Page 3

3 Jaing T, Lee W, Lin T, Huang J, Chen S, and Chow R, Successful Unrelated Mismatched Cord Blood Transplantation in an Infant with Severe Combined Immunodeficiency and Mycobacterium bovis Bacillus Calmette-Guèrin Disease Pediatric Transplantation (2006) 10:501-4 Jaing T, Hou J, Chen S, Huang I, Wang C, Lee W. Successful Unrelated Mismatched Cord Blood Transplantation in a Child with Malignant Infantile Osteopetrosis. Pediatr Transplant (2006) 10: Petz L, Branch D., Stock A, de Lange G, Rahbar S, Gallagher M, Yam P, Wallace R and Blume K: Endogenous stem cell repopulation after high dose pretransplant radiochemotherapy. Transplant. Proc. 17: , Transplantation Outcome & Selected References on StemCyte & Plasma Depleted Cord Blood Stem Cell Products Page 4

4 2007 BMT Tandem Meetings, Keystone, Colorado, February 8-12, 2007 Nademanee A, Graham M, Ballen K, Tan AM, Rosenthal J, Karanes C, Eames G, Tan P, Jaing T, Wang, B, Wu T, Gjertson D, Petz L, Chow R and Forman S. Adult Patients with Malignancies transplanted with Plasma Depleted Cord Blood (PD CB) - A Retrospective Audited Analysis of 68 patients (Abstract Submitted) Jaing T, Tan P, Rosenthal J, Chan L, Lin H, Tan P, Nademanee A, Karanes C, Gjertson D, Wang B, Petz L and Chow R. Unrelated Cord Blood Transplantation (UCBT) for Transfusion-Dependent Thalassemia - A Retrospective Audited Analysis of 41 Consecutive Patients (Abstract Submitted) Rosenthal J, Jaing T, Chan L, Eames G, Graham M, Tan A, Lin H, Nademanee A, Karanes C, Wang B, Chow T, Wu T, Tan P, Gjertson D, Petz L, Chow R and Forman S. Unrelated Cord Blood Transplantation (UCBT) for 59 Pediatric Patients with Benign Indications Using Plasma Depleted Cord Blood (PD CB) An Audited Retrospective Analysis. (Abstract Submitted) Graham M, Chan L, Eames G, Tan A, Tan PL, Rosenthal J, Nademanee A, Karanes C, Gjertson D, Wang B, Petz L and Chow R. Pediatric Patients with Malignancies transplanted with Plasma Depleted Cord Blood (PD CB). An Audited Analysis of 91 patients (Abstract Submitted) Ballen K, Nademanee A, Graham M, Jaing T, Tan P, Eames G, Rosenthal J, Karanes C, Gjertson D, Wang B, Petz L and Chow R. Outcomes of Double Cord Blood Transplantation (DCBT) in a Diverse Population (Abstract Submitted) Wang B, Tsukahara E, Wu T, Chow T, Lin A, Gjertson D, Petz L and Chow R. Comparison of Cell Dose and Outcome for Cord Blood Transplantation (CBT) sourced from Plasma Depleted (PD) Versus Red Cell Depleted (RD) Cord Blood Inventories. (Abstract Submitted) Chow R, Wang B, Wu T, Chow T, Gjertson D and Petz L. An Audited Retrospective Analysis of Cord Blood Transplantation (CBT) of 230 patients using Plasma Depleted Cord Blood Units (PD CB) (Abstract Submitted) 48 th ASH, Orlando, Florida, December 9-12, 2006 Jaing T, Tan P, Rosenthal J, Wang B, Gjertson D, Petz L, and Chow R, Unrelated Cord Blood Transplantation (CBT) for Thalassemia Blood (2006) 108 (Abstract In Press) Publication Number: 554. Rosenthal J, Jaing T, Nademanee A, Karanes C, Graham M, Chan L, Eames G, Tan A, Tan PL, Wang B, Tseng P, Chow T, Wu T, Lin H, Gjertson D, Petz L, Tan P, and Chow R. Hematopoietic Stem Cell Transplantation (HSCT) for Benign Indications Using Plasma Depleted Umbilical Cord Blood Units (UCB) That Were Not Depleted of Red Blood Cells. Blood (2006) 108 (Abstract In Press) Publication Number: B3151 Poster Board # NMDP Council Meeting, Minneapolis, Minnesota, November 10 12, 2006 Wang B, Wu T, Brown D, Tsukahara E, Chan W, Tonai R, Gindy L, Lin A, Yang S, Ho H, Olmstead J, Gjertson D, Petz L, and Chow R. Comparisons of outcome between NMDP- and Non-NMDP facilitated cord blood transplants from a single source. NMDP 2006 Council Meeting Abstract Book, p. Tsukahara E, Wang B, Wu T, Brown D, Chan W, Tonai R, Gindy L, Lin A, Yang S, Ho H, Olmstead J, Gjertson D, Petz L, and Chow R. Comparison of post-processing cord blood (CB) TNC count between cord blood banks (CBB) that practice plasma depletion (PD) versus red cell depletion (RD) processing. NMDP 2006 Council Meeting Abstract Book, p. 11 th Congress of Asia-Pacific Bone Marrow Transplant Group, Japan, October Wang B, Tseng P, Wu T, Chow T, Lin A, Yang S, Rosenthal J, Gjertson D, Petz L, Jaing J, Tan P, Sotomayor G, and Chow R. "Outcome comparisons between two cord blood banks on different continents using the same SOPs". 11 th Congress of Asia-Pacific Bone Marrow Transplant Group Symposium Abstract Handbook (2006) page 63 (Symposium Oral Abstract 2 S2-8). Transplantation Outcome & Selected References on StemCyte & Plasma Depleted Cord Blood Stem Cell Products Page 5

5 Wang B, Tseng P, Wu T, Chow T, Lin A, Yang S, Rosenthal J, Gjertson D, Petz L, Jaing T, Tan P, and Chow R, "Comparison of Cord Blood Transplant Outcome Between U.s. Versus Non-u.s. Transplant Centers for Cord Blood from A Single Source" 11 th Congress of Asia-Pacific Bone Marrow Transplant Group Symposium Abstract Handbook (2006) page 120 (Symposium Abstract P-31). Chow R, Nademanee A, Rosenthal J, Karanes C, Jaing T, Graham M, Wang B, Gjertson D, Chan L, Eames G, Tan A, Tan P, Lin H, Tan P, and Petz L, "Hematopoietic Cell Transplantation Using Plasma Depleted Cord Blood" " 11 th Congress of Asia-Pacific Bone Marrow Transplant Group Symposium Abstract Handbook (2006) page 121. (Abstract P-32). Jaing T, Tan P, Rosenthal J, Wang B, Gjertson D, Petz L, and Chow R, Unrelated Cord Blood Transplantation (CBT) for Thalassemia " 11 th Congress of Asia-Pacific Bone Marrow Transplant Group Symposium Abstract Handbook (2006) page 122 (Abstract P-33) AABB Annual Meeting, Miami Beach, Florida, October 21 24, 2006 Chow R, Wang B, Wu T, Brown R, Gindy L, Chan W, Santos S, Olmstead J, Gjertson D, Petz L, Post-Thaw Washing Prior to Transplantation of Umbilical Cord Blood Depleted of Plasma But Not of Red Blood Cells Transfusion (2006) 46: #9S:4-5A (Abstract S6-030B) Jaing T, Tan P, Chan L, Rosenthal J, Wang B, Gjertson D, Petz L, Chow R, Unrelated Cord Blood Transplantation (CBT) for Hemoglobinopathy Transfusion (2006) 46: #9S:55A (Abstract #:SP52) Chow R, Rosenthal J, Wang B, Wu T, Brown R, Gindy L, Tonai R, Olmstead J, Gjertson D, Petz L, Stem Cell Transplantation of Plasma Depleted Umbilical Cord Blood Transfusion (2006) 46: #9S:55-56A (Abstract #:SP54) 4 th Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, CA, May 19-20, 2006 Chow R, Nademanee A, Rosenthal J, Karanes C, Jaing T, Tan P, Graham M, Gjertson D, and Petz L Hematopoietic Stem Cell Transplantation (HSCT) using Plasma Depleted Umbilical Cord Blood Units (UCB) and the Effect of Post- Thaw Washing IN Wagner, J, Champlin, R, Petz, L. Proceedings of the 4 th Annual International Cord Blood Transplantation Symposium Biol. Blood & Marrow Transplantation (2006) In Press Jaing T, Tan P, Rosenthal J, and Chow R, Rapid and Durable Engraftment after Unrelated Cord Blood Transplantation (CBT) for Children with Transfusion-Dependent Thalassemia IN Wagner, J, Champlin, R, Petz, L. Proceedings of the 4 th Annual International Cord Blood Transplantation Symposium Biol. Blood & Marrow Transplantation (2006) In Press 2006 BMT Tandem Meetings, Honolulu, Hawaii, February 16-20, 2006 Chow R, Jaing T, Tan P, Rosenthal J., Nademanee, A, Karanes C, Graham M, Gjertson D, and Petz L Hematopoietic Stem Cell Transplantation (HSCT) for Benign Indications Using Umbilical Cord Blood Units (UCB) that were Not Depleted of Red Blood Cells. Biol. Blood & Marrow Transplantation (2006) 12: suppl. 1: 126. Chow R, Nademanee A, Rosenthal J, Karanes C, Graham M, Tan P, Jaing T, Gjertson D, and Petz L Hematopoietic Stem Cell Transplantation (HSCT) for Malignancies Using Umbilical Cord Blood Units (UCB) that were Not Red Blood Cell Depleted. Biol. Blood & Marrow Transplantation (2006) 12: suppl. 1: 87. Chow R, Nademanee A, Rosenthal J, Karanes C, Jaing T, Tan P, Graham M, Gjertson D, and Petz L Hematopoietic Stem Cell Transplantation (HSCT) using Umbilical Cord Blood Units (UCB) Not Depleted of Red Blood Cells Prior to Cryopreservation. Biol. Blood & Marrow Transplantation (2006) 12: suppl. 1: 101. Chow R, Nademanee A, Rosenthal J, Karanes C, Graham M, Tan P, Jaing T, Gjertson D, and Petz L Post-Thaw Washing Prior to Transplantation of Umbilical Cord Blood Units (UCB) that were Depleted of Plasma but Not of Red Blood Cells. Biol. Blood & Marrow Transplantation (2006) 12: suppl. 1: 103 Transplantation Outcome & Selected References on StemCyte & Plasma Depleted Cord Blood Stem Cell Products Page 6

6 10 th International conference for Thalassaemia and Haemoglobinopathies & 12 th International TIF Conference for Thalassaemia Patients & Parents, Dubai, UAE, January 7-10, 2005 Chow R, Al Shemmari, S, Jaing T, Tan P, Rosenthal J, Nademanee A, Karanes C, Graham M, Gjertson D, and Petz L, Hematopoietic Stem Cell Transplantation (HSCT) for Benign Indications Using Umbilical Cord Blood Units (UCB) that were Not Depleted of Red Blood Cells 10 th International conference for Thalassaemia and Haemoglobinopathies & 12 th International TIF Conference for Thalassaemia Patients & Parents, Dubai, UAE, January 7-10, 2006, Abstract 376 Jaing T, Al Shemmari, S, Rosenthal J, and Chow R, Rapid and Durable Engraftment after Unrelated Cord Blood Transplantation (CBT) for Children with Transfusion-Dependent Thalassemia 10 th International conference for Thalassaemia and Haemoglobinopathies & 12 th International TIF Conference for Thalassaemia Patients & Parents, Dubai, UAE, January 7-10, 2006, Abstract th ASH, Atlanta, Georgia, December 10-13, 2005 Chow R, Gjertson D, Rosenthal J, Nademanee A, Karanes C, Jaing T, Graham M, Tan P, and Petz L Clinical Outcome of Hematopoietic Stem Cell Transplantation (HSCT) using Plasma Depleted Umbilical Cord Blood Units (UCB) that were Not Depleted of Red Blood Cells Prior to Cryopreservation. Blood (2005) 106:578a Chow R, Gjertson D, Rosenthal J, Nademanee A, Karanes C, Jaing T, Graham M, Tan P, and Petz L Effect of Post- Thaw Washing Prior to Transplantation of Umbilical Cord Blood Units (UCB) that were Depleted of Plasma but Not of Red Blood Cells Blood (2005) 106:405b Chow R, Jaing T, Gjertson D, Rosenthal J, Nademanee A, Karanes C, Graham M, Tan P, and Petz L Hematopoietic Stem Cell Transplantation (HSCT) for Benign Indications Using Umbilical Cord Blood Units (UCB) that were Depleted of Plasma (PD) but Not of Red Blood Cells. Blood (2005) 106:451b 2005 NMDP Council Meeting, Minneapolis, Minnesota, Nov. 4-6, 2005 Chow R, Jaing T, Gjertson D, Rosenthal J, Nademanee A, Karanes C, Graham M, Tan P, and Petz L Hematopoietic Stem Cell Transplantation (HSCT) for Benign Indications Using Umbilical Cord Blood Units (UCB) that were Depleted of Plasma (PD) but Not of Red Blood Cells. NMDP 2005 Council Meeting Abstract Book, p. 8 Chow R, Gjertson D, Graham M, Rosenthal J, Nademanee A, Karanes C, Tan P, Jaing T, and Petz L Hematopoietic Stem Cell Transplantation (HSCT) for Malignancies Using Umbilical Cord Blood Units (UCB) that were Depleted of Plasma (PD) but Not of Red Blood Cells NMDP 2005 Council Meeting Abstract Book, p th ASH Meeting, San Diego, California, December 6-9, 2003 Krieg R, Petz, L, Mehdikhani A, Chow R, Gindy L, Lan J, Data on the time between confirmatory typing (CT) request and request to ship date, the request to ship date and shipment date, and CT to transplant ratios. Blood (2003) 102: 418b. Chow R, Mehdikhani A, Gindy L, Krieg R, Petz L, A proposal for standardization of total nucleated cell (TNC) and viability data reporting, Blood (2003) 102: 419b. Petz L, Krieg R, Mehdikhani A, Chow R, Gindy L, Lan J, Assuring the identity of cord blood units released for transplantation by HLA typing of maternal samples, Blood (2003) 102: 418b NMDP Council Meeting, Minneapolis, Minnesota Chow R, Mehdikhani A, Gindy L, Krieg R, Petz L, Reporting of post-processing TNC and post-thaw nucleated cell recovery and viability, NMDP Annual Council Meeting, November 14-16, Transplantation Outcome & Selected References on StemCyte & Plasma Depleted Cord Blood Stem Cell Products Page 7

7 Krieg R, Petz L, Mehdikhani A, Chow R, Gindy L, Lan, J., Data on the time between confirmatory typing (CT) request and request to ship date, the request to ship date and shipment date, and CT to transplant ratios NMDP Annual Council Meeting, November 14-16, Petz L, Krieg R, Mehdikhani A, Chow R, Gindy L, Lan J, Assuring the identity of cord blood units released for transplantation by HLA typing of maternal samples, NMDP Annual Council Meeting, November 14-16, th ASHI Meeting, Florida, October 28 November 1, 2003 Senitzer D, Tonai R, Santos S, Box B, Krieg R, Chow R, Petz L, Experiences of StemCyte umbilical cord blood bank, ASHI Conference, Miami, Florida, October 28 November 1, rd ASH Meeting, Orlando, Florida, December 7-11, 2001 Hirose, T., Punzalan, R. R., Tan, P., Yap, C., Tsukahara E., Gindy L, Won, W., Mehdikhani A, Tonai, R., Hunicutt, J., Anthony, D., Hughes, D., Krieg R, Cramer, S., Rodgerson, D., Kuan, A., Petz L, & Chow R, A comparison of Maternal Infectious Disease Marker Rates in Taiwanese and USA Umbilical Cord Blood Donors. Blood (2001) 98:106b. 3 rd International Indianapolis Conference/Workshop, Indianapolis, Indiana, April 30 and May 1, 2001 Punzalan R, Chow R, Hirose T, Yap C, Silva M, Rodgerson D, Tonai R, Krieg R, Tsukahara E, Anthony D, Chin L, Yang C, Chiang L, Fraser J, and Petz L, A Model for an International Cord Blood Bank, Proceedings of the Third International Indianapolis Conference/Workshop Recent Developments in Cord Blood Stem and Progenitor Cell Transplantation and Biology, Indianapolis, Indiana, April 30 and May 1, Fraser J, Hirose T, Punzalan R, Yap C, Tsukahara E, Silva M, Anthony D, Gindy L, Rodgerson D, Tonai R, Chin L, Yang C, Chiang L, Krieg R, Chow R, and Petz L, Comparison of Two Umbilical Cord Blood Bank Models, Proceedings of the Third International Indianapolis Conference/Workshop Recent Developments in Cord Blood Stem and Progenitor Cell Transplantation and Biology, Indianapolis, Indiana, April 30 and May 1, Hirose T, Punzalan R, Fraser J, Yap C, Tsukahara E, Silva M, Chin L, Yang C, Chiang L, Tonai R, Anthony D, Hughes D, Krieg R, Rodgerson R, Petz L, and Chow R. Establishment of an International Umbilical Cord Stem Cell Bank by Applying International Standards for Quality Management. Proceedings of the Third International Indianapolis Conference/Workshop Recent Developments in Cord Blood Stem and Progenitor Cell Transplantation and Biology, Indianapolis, Indiana, April 30 and May 1, th Congress of Asia-Pacific Bone Marrow Transplant Group, Bangkok, Thailand, November 5-8, 2000 Chow R, Hirose T, Punzalan R, Yap C, Tsukahara E, Silva M, Petz L, Rodgerson D, Tonai R, Krieg R, and Fraser J, StemCyte - a model for an international umbilical cord blood bank Proceedings of The 7 th Congress of Asia-Pacific Bone Marrow Transplant Group, Bangkok, Thailand, November 5-8, Fraser J, Hirose T, Punzalan R, Yap C, Tsukahara E, Silva M, Petz L, Rodgerson D, Tonai R, Krieg R, and Chow R, UCLA Cord blood bank and StemCyte, Inc. cord blood bank a comparison of two cord blood banks Proceedings of The 7 th Congress of Asia-Pacific Bone Marrow Transplant Group, Bangkok, Thailand, November 5-8, Transplantation Outcome & Selected References on StemCyte & Plasma Depleted Cord Blood Stem Cell Products Page 8

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION

More information

Public Cord Blood Banking at the National Cord Blood Program (NCBP)

Public Cord Blood Banking at the National Cord Blood Program (NCBP) Public Cord Blood Banking at the National Cord Blood Program (NCBP) A. Scaradavou, MD Medical Director, National Cord Blood Program, New York Blood Center Associate Attending, Pediatric BMT Memorial Sloan-Kettering

More information

Umbilical Cord Blood Transplantation

Umbilical Cord Blood Transplantation Umbilical Cord Blood Transplantation V Rocha MD, PhD Hopital Saint Louis, Paris University 7 CIBMTR Milwaukee Umbilical Cord blood transplantation Background History Clinical results in children and adults

More information

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation

More information

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us

More information

The donor search: the best donor or cord blood unit

The donor search: the best donor or cord blood unit The donor search: the best donor or cord blood unit Dr Bronwen Shaw Consultant in haematopoietic cell transplantation Royal Marsden Hospital /Anthony Nolan Overview Where do we find donors/units for transplantation

More information

Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant. Recipients

Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant. Recipients Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant Recipients Filippo Milano, 1 J. Lee Nelson, 1, 2 Colleen Delaney 1,3 1 Clinical Research Division, Fred Hutchinson Cancer Research

More information

Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit. Karen Ballen, MD Massachusetts General Hospital June, 2012

Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit. Karen Ballen, MD Massachusetts General Hospital June, 2012 Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit Karen Ballen, MD Massachusetts General Hospital June, 2012 OUTLINE Cell Dose HLA Typing HLA C and KIR HLA Antibodies ABO and Racial/Ethnic

More information

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose Pr Eliane Gluckman, MD, FRCP, Hospital Saint Louis, University Paris- Diderot, France Should Haplo-identical transplantation be preferred to cord blood in patients without a matched donor? Disclosure of

More information

Asian Harmonization via Cord Blood Bank Network

Asian Harmonization via Cord Blood Bank Network Asian Harmonization via Cord Blood Bank Network Introduced by Shigetaka Asano Of Tokyo Cord Blood Bank SCA 200, Seoul Country China Indonesia Philippines Vietnam Japan Thailand Myanmar Korea Malaysia Cambodia

More information

What we will discuss today

What we will discuss today Umbilical cord blood banking It s Utility? Dr. Nita Radhakrishnan Pediatric Hematology Oncology Unit, Sir Ganga Ram Hospital, New Delhi What we will discuss today What are stem cells? What are the sources

More information

Selecting an appropriately matched donor for hematopoietic

Selecting an appropriately matched donor for hematopoietic Transplant Outcomes in Acute Leukemia (I) Mary Eapen a and John E. Wagner b Umbilical cord blood (UCB) has gradually emerged over the last decade as an alternative source of hematopoietic cells for transplantation

More information

A Cure for Sickle Cell Anemia and Thalassemia

A Cure for Sickle Cell Anemia and Thalassemia IV Simpósio Internacional de Hemoglobinopatias A Cure for Sickle Cell Anemia and Thalassemia Bertram Lubin, MD and Mark Walters, MD 4 September 2007 Topics to be covered Cord blood: Importance and biology

More information

Selection of the Optimal Umbilical Cord Blood Unit

Selection of the Optimal Umbilical Cord Blood Unit Karen Ballen, MD Selection of the Optimal Umbilical Cord Blood Unit Massachusetts General Hospital September, 2013 OUTLINE Cell Dose HLA Match Allele Level HLA C KIR Directional Mismatch NIMA HLA Antibodies

More information

Cord Blood Stem Cell Transplantation

Cord Blood Stem Cell Transplantation LEUKEMIA LYMPHOMA MYELOMA FACTS Cord Blood Stem Cell Transplantation No. 2 in a series providing the latest information on blood cancers Highlights Umbilical cord blood, like bone marrow and peripheral

More information

Cord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program

Cord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program Cord Blood: that other stem cell source Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program CBMTG April 2012 The problem: In order to perform a BMT from one person to another one needs

More information

In contrast to the very high transplant-related

In contrast to the very high transplant-related Cord Blood: an Alternative Stem Cell Source or a New Standard? Juliet N. BARKER Memorial Sloan-Kettering Cancer Center, NY, ABD In contrast to the very high transplant-related mortality (TRM) associated

More information

Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between

Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program ISCT 2012 Disclosures: none The problem:

More information

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Background Hematopoietic stem cell transplantation (HSCT) is

More information

Umbilical Cord Blood Stem Cells Current Status & Future Potential

Umbilical Cord Blood Stem Cells Current Status & Future Potential Umbilical Cord Blood Stem Cells Current Status & Future Potential Natasha Ali Assistant Professor Haematology Department of Pathology & Laboratory Medicine/Oncology The Aga Khan University Email: natasha.ali@aku.edu

More information

Cord Blood Market Trends, circa 2014

Cord Blood Market Trends, circa 2014 GENReports: Market & Tech Analysis Cord Blood Market Trends, circa 2014 > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. enal@selectbio.us Topic Introduction and Scope The focus of this GEN

More information

Recommendations to Transplant Centres Performing Cord Blood Transplants. Why Choosing the Right Thaw Method Could Save a Patient s Life

Recommendations to Transplant Centres Performing Cord Blood Transplants. Why Choosing the Right Thaw Method Could Save a Patient s Life Recommendations to Transplant Centres Performing Cord Blood Transplants Vicki Antonenas Why Choosing the Right Thaw Method Could Save a Patient s Life Lynn O Donnell (USA) 1 The process of receiving, testing

More information

Natasha Kekre, 1 Jennifer Philippe, 2 Ranjeeta Mallick, 3 Susan Smith, 2 and David Allan 1,2,4. 1. Introduction

Natasha Kekre, 1 Jennifer Philippe, 2 Ranjeeta Mallick, 3 Susan Smith, 2 and David Allan 1,2,4. 1. Introduction Hindawi Publishing Corporation Stem Cells International Volume 2013, Article ID 124834, 6 pages http://dx.doi.org/10.1155/2013/124834 Research Article Modelling Improvements in Cell Yield of Banked Umbilical

More information

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases ! 21%! EUROCORD 6756 cord blood transplantations performed from 1988 to March 2010 in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases * missing center

More information

Challenges of Hematopoietic Stem Cell Transplantation. Robert J. Soiffer, MD Dana Farber Cancer Institute

Challenges of Hematopoietic Stem Cell Transplantation. Robert J. Soiffer, MD Dana Farber Cancer Institute Challenges of Hematopoietic Stem Cell Transplantation Robert J. Soiffer, MD Dana Farber Cancer Institute Hematopoietic Stem Cell Transplantation Objectives Deliver sufficient chemo-radio therapy to destroy

More information

Navelstrengbloed tegen kanker

Navelstrengbloed tegen kanker Navelstrengbloed tegen kanker THERAPIEDAG 2008: "Zorgtrajecten in kanker" Zaterdag 27 september 2008 Gasthuisberg, Leuven. Hélène Schoemans, MD KUL, Stem Cell Institute Leuven Cord blood Collection and

More information

Selecting Appropriate Blood Products for Recipients of ABO/Rh Mismatched Stem Cell Transplants. Summary of Significant Changes. Purpose.

Selecting Appropriate Blood Products for Recipients of ABO/Rh Mismatched Stem Cell Transplants. Summary of Significant Changes. Purpose. This Specification replaces SPN/DDR/RC/023/05 (SPN215/1) Copy Number Summary of Significant Changes Change to new document reference numbers. Effective 18/10/11 Removal of ABO titres from sections 3.1

More information

Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center

Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center (last updated May 13, 2004) This is an activity offered by CBBS, a CMA accredited provider. Physicians attending this course may report up to 13.25 hours of Category 1 credits toward the California Medical

More information

Cord Blood Transplant. E. Gluckman Eurocord ESH-EBMT training course Vienna 2014

Cord Blood Transplant. E. Gluckman Eurocord ESH-EBMT training course Vienna 2014 Cord Blood Transplant E. Gluckman Eurocord ESH-EBMT training course Vienna 2014 Background Since 1988, umbilical cord blood (CB) has been successfully used to treat children and adults needing stem cell

More information

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Pros and Cons of Stem Cell Sources and their availability in Africa Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Introduction The ability to perform a haematopoietic stem

More information

CPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD

CPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD The blood and marrow transplant field has 15 dedicated CPT codes. These CPT codes can be categorized into three groups: 1. Collection Codes 2. Cell Processing Codes 3. Cell Infusion Codes Collection Codes

More information

Placental/Umbilical Cord Blood as a Source of Stem Cells. Original Policy Date

Placental/Umbilical Cord Blood as a Source of Stem Cells. Original Policy Date MP 7.01.38 Placental/Umbilical Cord Blood as a Source of Stem Cells Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013

More information

Preamble. 1. If it is necessary, are you willing to receive follow up questions to help clarify any answers to the survey questions?

Preamble. 1. If it is necessary, are you willing to receive follow up questions to help clarify any answers to the survey questions? Preamble The purpose of this inter organizational survey is to gather data regarding transplant center practices for preparing cord blood units for administration, including characterizing and confirming

More information

Disclosures. I have no disclosures.

Disclosures. I have no disclosures. Not Your Own Marrow Jenni Krajewski, MD Clinical Assistant Professor, Rutgers New Jersey Medical School Attending Physician, Pediatric Blood and Marrow Transplantation The Institute for Pediatric Cancer

More information

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Bone Marrow Transplantation

More information

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and

More information

Stem Cell Transplantation

Stem Cell Transplantation Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance

More information

Cord Blood Banking and Biologic License Application (BLA) November 19, 2010

Cord Blood Banking and Biologic License Application (BLA) November 19, 2010 Cord Blood Banking and Biologic License Application (BLA) November 19, 2010 1 Webinar Presenters Tara Sadeghi, BS University of Texas MD Anderson Cord Blood Bank Michele Carbone, MS, CLS, MT(ASCP)SH,DLM,CQM,

More information

TRANSFUSION SUPPORT FOR HEMOTOPOIETIC STEM CELL TRANSPLANT (HSCT) PATIENTS. Shan Yuan, MD Updated April 2011

TRANSFUSION SUPPORT FOR HEMOTOPOIETIC STEM CELL TRANSPLANT (HSCT) PATIENTS. Shan Yuan, MD Updated April 2011 TRANSFUSION SUPPORT FOR HEMOTOPOIETIC STEM CELL TRANSPLANT (HSCT) PATIENTS Shan Yuan, MD Updated April 2011 Introduction HSCT increasingly performed with better clinical outcomes, and expanding indications.

More information

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD Cord Blood Banking Scott N. Furlan, MD Ellen S.Plummer, MD Overview Background Biology of Stem Cell Transplant Opportunities i at Parkland Logistics of Banking Potential Barriers Indications for HCT Cancer

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

Placental and Umbilical Cord Blood as a Source of Stem Cells

Placental and Umbilical Cord Blood as a Source of Stem Cells Placental and Umbilical Cord Blood as a Source of Stem Cells Policy Number: 7.01.50 Last Review: 12/2013 Origination: 12/2001 Next Review: 12/2014 Policy Blue Cross and Blue Shield of Kansas City (Blue

More information

Stem Cell Transplantation in Severe Aplastic Anemia

Stem Cell Transplantation in Severe Aplastic Anemia Stem Cell Transplantation in Severe Aplastic Anemia Dr. D. Goodyear MD, FRCPC Division of Hematology and Hematological Malignancies, University of Calgary 1 of 11 Introduction Most cases of aplastic anemia

More information

Sibling Donor Cord Blood Transplantation for Thalassemia Major: Experience of the Sibling Donor Cord Blood Program

Sibling Donor Cord Blood Transplantation for Thalassemia Major: Experience of the Sibling Donor Cord Blood Program Sibling Donor Cord Blood Transplantation for Thalassemia Major: Experience of the Sibling Donor Cord Blood Program MARK C. WALTERS, LYNN QUIROLO, ELIZABETH T. TRACHTENBERG, SANDIE EDWARDS, LISA HALE, JOANNA

More information

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cell Transplantation Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cells Harvested from blood, bone marrow, umbilical cord blood Positive selection of CD34 (+) cells

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

Processing & Utilization of Cord Blood for Transplant

Processing & Utilization of Cord Blood for Transplant Processing & Utilization of Cord Blood for Transplant 2010-Jan Jan-15 Nicole L. Prokopishyn, PhD HPC Processing Laboratory Director Calgary Laboratory Services Overview Cord Blood Processing Pre-Freeze

More information

The Impact of Maternal, Neonatal and Collections factors on the TNC count of an Umbilical Cord Blood Donation

The Impact of Maternal, Neonatal and Collections factors on the TNC count of an Umbilical Cord Blood Donation The Impact of Maternal, Neonatal and Collections factors on the TNC count of an Umbilical Cord Blood Donation By: NHS Cord Blood Bank (Colindale Laboratory) Date: 26 th September 2014 NHS insert Cord your

More information

TRANSFUSION MEDICINE

TRANSFUSION MEDICINE TRANSFUSION MEDICINE Transfusion medicine is a one-month per year rotation for a total of three months. During each rotation the resident is exposed to the basic concepts of transfusion medicine. Specific

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll

More information

Cigna Medical Coverage Policy

Cigna Medical Coverage Policy Cigna Medical Coverage Policy Subject Umbilical Cord Blood Banking Table of Contents Coverage Policy... 1 General Background... 1 Coding/Billing Information... 3 References... 4 Effective Date... 6/15/2014

More information

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries

More information

Transmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014

Transmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014 FACT Accreditation for Cord Blood Banks and Cellular Therapy Nadim Mahmud, MD, PhD Associate Professor of Medicine Division of Hematology/Oncology Director, Hospital Stem Cell Laboratory Blood & Marrow

More information

Blood-Forming Stem Cell Transplants

Blood-Forming Stem Cell Transplants Blood-Forming Stem Cell Transplants What are bone marrow and hematopoietic stem cells? Bone marrow is the soft, sponge-like material found inside bones. It contains immature cells known as hematopoietic

More information

Saving your baby s s cord blood: Is this good insurance?

Saving your baby s s cord blood: Is this good insurance? Saving your baby s s cord blood: Is this good insurance? 32 th SEMINAR ON PERINATAL MEDICINE CONTROVERSIES IN PERINATAL MEDICINE: EVIDENCE FOR CURRENT PRACTICE Sante Fe, New Mexico Mervin C. Yoder, MD

More information

Cord Blood Transplant Past and Future. E. Gluckman Eurocord ISCT Paris 24/04/2014

Cord Blood Transplant Past and Future. E. Gluckman Eurocord ISCT Paris 24/04/2014 Cord Blood Transplant Past and Future E. Gluckman Eurocord ISCT Paris 24/04/2014 Background Since 1988, umbilical cord blood (CB) has been successfully used to treat children and adults needing stem cell

More information

Public Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden

Public Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden HOUSE OF REPRESENTATIVES COMMITTEE ON HEALTH CARE SERVICES ANALYSIS BILL #: HB 2337 (PCB HCS 00-07) RELATING TO: SPONSOR(S): TIED BILL(S): Public Cord Blood Tissue Bank Committee on Health Care Services

More information

Objectives. Cord Blood. Case 1. Case 1. Case 1. Case 1. To provide a framework for answering a family s questions about cord blood storage.

Objectives. Cord Blood. Case 1. Case 1. Case 1. Case 1. To provide a framework for answering a family s questions about cord blood storage. Cord Blood Should we save the baby s cord blood? Meghan A. Higman, MD, PhD Clinical Assistant Professor of Pediatrics Division of Pediatric Hematology/Oncology Assistant Professor of Oncology Pediatrics

More information

Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies Craig Sauter and Juliet N.

Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies Craig Sauter and Juliet N. Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies Craig Sauter and Juliet N. Barker Adult Allogeneic Bone Marrow Transplantation Service, Memorial Sloan-Kettering

More information

Not All Stem Cells are the Same

Not All Stem Cells are the Same Cord Blood Banking and Transplantation Jennifer Willert, M.D. Hematology/Oncology Blood and Marrow Transplant Rady Children s Hospital San Diego Clinical Professor UCSD Not All Stem Cells are the Same

More information

Hematopoietic Stem Cells, Stem Cell Processing, and Transplantation

Hematopoietic Stem Cells, Stem Cell Processing, and Transplantation Hematopoietic Stem Cells, Stem Cell Processing, and Joseph (Yossi) Schwartz, MD Director, Hemotherapy and Stem Cell Processing Facility E-mail: js2745@columbia.edu A 40-year old man with acute myelogenous

More information

Cord Blood: Thawing & Infusion Practical Methods

Cord Blood: Thawing & Infusion Practical Methods Cord Blood: Thawing & Infusion Practical Methods Donna M Regan, MT(ASCP)SBB St. Louis Cord Blood Bank @ SSM Cardinal Glennon Children s s Medical Center Objectives Present variety of product configurations

More information

Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer

Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem_cell_transplantation_for_breast_cancer

More information

The Value of Cord Blood Stem Cells. Mona Shafey, MD, FRCPC Medical Grand Rounds October 25 th, 2011

The Value of Cord Blood Stem Cells. Mona Shafey, MD, FRCPC Medical Grand Rounds October 25 th, 2011 The Value of Cord Blood Stem Cells Mona Shafey, MD, FRCPC Medical Grand Rounds October 25 th, 2011 Objectives To discuss umbilical cord blood as a stem cell source and the role of umbilical cord blood

More information

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7 10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in

More information

ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012

ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012 ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012 PAGE 1 OF 7 PRINCIPLES FOR A NEW ALGORITHM Once cord blood transplantation (CBT) is

More information

A Public Cord Blood Bank for South Africa? i

A Public Cord Blood Bank for South Africa? i No. 42/2007 A Public Cord Blood Bank for South Africa? i By Dr Robert Crookes MBChB (Wits), Dip. Internal Medicine (American Board of Internal Medicine, USA) Transfusion Medicine Consultant. South African

More information

CORD BLOOD BANKING FAQ

CORD BLOOD BANKING FAQ CORD BLOOD BANKING FAQ Cord Blood & Stem Cells Q: What is umbilical cord blood (UCB)? A: Bone marrow, peripheral blood and UCB constitute the three primary sources of stem cells. Cord blood, which, until

More information

The Power & Potential of Cord Blood

The Power & Potential of Cord Blood The Power & Potential of Cord Blood Donna Regan, MT(ASCP)SBB, Director St. Louis Cord Blood Bank & Cellular Therapy Laboratory SSM Cardinal Glennon Children s Medical Center April 30, 2014 Objectives Since

More information

CIGNA HEALTHCARE COVERAGE POSITION

CIGNA HEALTHCARE COVERAGE POSITION CIGNA HEALTHCARE COVERAGE POSITION Subject Umbilical Cord Blood Banking Table of Contents Coverage Position... 1 General Background... 1 Coding/Billing Information... 3 References... 3 Revised Date...

More information

Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD

Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD Stem Cell Transplantation and the Canadian First Nations Community Becky Luk (PTLS) Tanya Petraszko, MD Why is there a need for stem cells? Our Story Why are we engaging the First Nations, Metis and Inuit

More information

Jamie Peregrine, MD, PGY-4 KU-Wichita, OB/GYN Wesley Medical Center

Jamie Peregrine, MD, PGY-4 KU-Wichita, OB/GYN Wesley Medical Center Jamie Peregrine, MD, PGY-4 KU-Wichita, OB/GYN Wesley Medical Center Uses for umbilical cord stem cells Describe the indications and uses for umbilical cord stem cells. Counsel patients on the advantages

More information

Hematopoiesis i starts from. HPC differentiates t to sequentially more mature. HPC circulate in very low

Hematopoiesis i starts from. HPC differentiates t to sequentially more mature. HPC circulate in very low Upstate Cord Blood Bank Hematopoietic Progenitor Cells Hematopoiesis i starts from self renewing HPC HPC differentiates t to sequentially more mature blood cells HPC circulate in very low numbers in adults

More information

CORD BLOOD TRANSPLANTATION: PAST, PRESENT AND FUTURE

CORD BLOOD TRANSPLANTATION: PAST, PRESENT AND FUTURE CORD BLOOD TRANSPLANTATION: PAST, PRESENT AND FUTURE Dennis M. Todd, Ph.D. The New Jersey Cord Blood Bank a Division of Bergen Community Regional Blood Center Montvale, NJ Hematopoietic Stem Cell Transplantation

More information

Graft Failure After HSCT

Graft Failure After HSCT Graft Failure After HSCT Vanderson Rocha, MD, PhD Professor of Haematology- Oxford University Bone Marrow Transplant Unit- Sirio Libanes Hospital- Sao Paulo Scientific Director of Eurocord-Paris Clinical

More information

UMBILICAL CORD BANKING. (formerly Unistem Biosciences Pvt.Ltd.)

UMBILICAL CORD BANKING. (formerly Unistem Biosciences Pvt.Ltd.) UMBILICAL CORD BANKING (formerly Unistem Biosciences Pvt.Ltd.) INITIATIVES OF CELLUGEN BIOTECH PVT.LTD. (formerly Unistem Biosciences Pvt.Ltd.) UMBILICAL CORD BANKING UMBILICAL CORD STEM CELL THERAPY Stem

More information

Placental and Umbilical Cord Blood as a Source of Stem Cells

Placental and Umbilical Cord Blood as a Source of Stem Cells Placental and Umbilical Cord Blood as a Source of Stem Cells Policy Number: 7.01.50 Last Review: 12/2014 Origination: 12/2001 Next Review: 12/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue

More information

Cord Blood: Research Progress and Future Promise

Cord Blood: Research Progress and Future Promise Cord Blood: Research Progress and Future Promise By Al Staropoli, AABB Contributing Writer Sue Fister found out she had leukemia when she was 50 years old. Doctors suggested a bone marrow transplant as

More information

Guidance for Industry and FDA Staff

Guidance for Industry and FDA Staff Guidance for Industry and FDA Staff Investigational New Drug Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution

More information

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient

More information

Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP)

Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP) Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP) October 18, 2014 19th Congress of APBMT, Hangzhou, China AMIR ALI HAMIDIEH, MD Iranian

More information

Hematologic Malignancies/Stem Cell Transplantation Program Clinical Section UCLA Health System Los Angeles, CA 90095

Hematologic Malignancies/Stem Cell Transplantation Program Clinical Section UCLA Health System Los Angeles, CA 90095 Clinical Section UCLA Health System Los Angeles, CA 90095 CS 6.2 DIAGNOSIS AND MANAGEMENT OF INTERSTITIAL PNEUMONIA Location: Clinical Section Supersedes/Replaces: B3.421g Document drive\path\name Effective

More information

Placental and Umbilical Cord Blood as a Source of Stem Cells

Placental and Umbilical Cord Blood as a Source of Stem Cells Placental and Umbilical Cord Blood as a Source of Stem Cells Policy Number: 7.01.50 Last Review: 12/2015 Origination: 12/2001 Next Review: 12/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue

More information

SAVE A LIFE... BY GIVING LIFE!

SAVE A LIFE... BY GIVING LIFE! SAVE A LIFE... BY GIVING LIFE! FOLLOW US ON: HÉMA-QUÉBEC PUBLIC CORD BLOOD BANK www.hema-quebec.qc.ca Scan this code with your smart phone to access the page Register to the Public Cord Blood Bank on the

More information

information for payers and referrers

information for payers and referrers a d u lt s t e m c e l l t r a n s p l a n tat i o n p r o g r a m information for payers and referrers Spring 2014 For more information, visit www.dfbwcc.org/bmt. o u r expertise Since its founding in

More information

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood [Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,

More information

Stem Cell Background Paper

Stem Cell Background Paper Stem Cell Background Paper Introduction...2 Stem Cell Basics...3 Stem Cell Process Flow...9 Comparison of Blood, Stem Cells, Tissues and Organs Processes...10 Responsibilities for the Blood, Stem Cells,

More information

Economics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015

Economics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015 Economics of Cord Blood Banking Michael Boo NMDP Be The Match September 11, 2015 Historical Use UCB Use Data 2 NMDP Historical Transplants by Product 7,000 6,500 6,000 5,500 5,000 4,500 4,000 3,500 3,000

More information

Section: Transplant Last Reviewed Date: January 2015. Policy No: 45.16 Effective Date: April 1, 2015

Section: Transplant Last Reviewed Date: January 2015. Policy No: 45.16 Effective Date: April 1, 2015 Medical Policy Manual Topic: Placental and Umbilical Cord Blood as a Source of Stem Cells Date of Origin: December 2009 Section: Transplant Last Reviewed Date: January 2015 Policy No: 45.16 Effective Date:

More information

hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.

hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge. hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.ch Spring water: Manufactured by nature COSTLESS Cord Blood:

More information

Myeloablative versus Reduced Intensity Conditioning Regimen Cord Blood Transplants

Myeloablative versus Reduced Intensity Conditioning Regimen Cord Blood Transplants Educational 2 Cord Blood Transplantation Myeloablative versus Reduced Intensity Conditioning Regimen Cord Blood Transplants William Arcese University of Rome Tor Vergata Rome Transplant Network 4th April

More information

Directed/Related Cord Blood Collection by NHS Blood and Transplant

Directed/Related Cord Blood Collection by NHS Blood and Transplant Directed/Related Cord Blood Collection by Jacqui Thompson Clinical Scientist Section Head of Specialist Procedures Stem Cells and Immunotherapies Department National Blood Service, NHSBT Birmingham Why

More information

Detroit, MI 48202. PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012

Detroit, MI 48202. PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 AD AWARD NUMBER: W81XWH-05-1-0266 TITLE: Cord Blood Stem Cell Procurement in Minority Donors PRINCIPAL INVESTIGATOR: Voravit Ratanatharathorn, M.D. CONTRACTING ORGANIZATION: Wayne State University Detroit,

More information

Statement of Joanne Kurtzberg, M.D.

Statement of Joanne Kurtzberg, M.D. Statement of Joanne Kurtzberg, M.D. President of the Cord Blood Association Jerome Harris Distinguished Professor of Pediatrics and Pathology Chief Scientific Officer and Medical Director, Robertson Clinical

More information

Stem Cell Transplantation In Patients with Fanconi Anemia

Stem Cell Transplantation In Patients with Fanconi Anemia Stem Cell Transplantation In Patients with Fanconi Anemia FARF Annual Family Meeting 6/28/15 Casco, ME Parinda A. Mehta, M.D. Cincinnati Children s Hospital Medical Center Improvements in Unrelated Donor

More information

The Power & Potential of Cord Blood

The Power & Potential of Cord Blood The Power & Potential of Cord Blood Donna Regan, MT(ASCP)SBB, Director St. Louis Cord Blood Bank & Cellular Therapy Laboratory SSM Cardinal Glennon Children s Medical Center September 18, 2013 Objectives

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): 4/1/2011 Most Recent Review Date (Revised): 3/24/2015 Effective Date: 6/1/2015 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER

More information

5th International Advanced ICAS Training Course on "Blood Stem Cell Transplantation: State of the Arts, Methods and Perspectives" 22-25 June 2009

5th International Advanced ICAS Training Course on Blood Stem Cell Transplantation: State of the Arts, Methods and Perspectives 22-25 June 2009 International Center for Advanced Studies in Health Sciences and Services (ICAS) of the Medical Faculty, University of Ulm Germany http://icas.uni-ulm.de 5th International Advanced ICAS Training Course

More information

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science,

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Lancaster University, UK Today Exploring Perceptions of 'Quality'

More information